Radiotherapy and cellular signalling

The Lancet Oncology
C R Lewanski, W J Gullick

Abstract

Developments in cellular and molecular biology in the past decade have increased our understanding of the processes by which cells respond to ionising radiation. Cells use complex protein signalling systems that recognise radiation damage to DNA and plasma membrane lipids. When damage is found, it leads to the activation of various intracellular pathways that modulate the activity of genes controlling ceflular responses such as apoptosis, cell-cycle arrest, or repair. Numerous molecular targets may be activated or inhibited in an attempt to upregulatre or downregulate the radiation response. In this review, we discuss some of the new compounds and techniques for manipulating the cell's response to radiation.

References

Aug 1, 1995·Nature Medicine·D E HallahanR R Weichselbaum
Jul 1, 1994·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S DelanianM Housset
Aug 1, 1994·The Journal of Experimental Medicine·A Haimovitz-FriedmanR N Kolesnick
Jan 12, 1996·The Journal of Biological Chemistry·K A Thomas
Jun 4, 1999·Antisense & Nucleic Acid Drug Development·P C GokhaleU Kasid
May 10, 2000·International Journal of Radiation Oncology, Biology, Physics·M MartinS Delanian

❮ Previous
Next ❯

Citations

Mar 20, 2013·Archives of Pharmacal Research·Nizar M MhaidatRick T Thorne
Dec 24, 2005·Apoptosis : an International Journal on Programmed Cell Death·C Di PietroM Purrello
Nov 23, 2011·Phytotherapy Research : PTR·Nizar M MhaidatRick F Thorne
Jun 4, 2014·Journal of Biochemical and Molecular Toxicology·Emel SaglarHatice Mergen
Dec 2, 2008·Journal of Cellular and Molecular Medicine·Lyndsay DaviesLuminita Paraoan
Jan 15, 2014·Cellular & Molecular Biology Letters·Qiu ChenJun Hou
Jun 2, 2016·Nature Reviews. Clinical Oncology·Ricky A SharmaUNKNOWN NCRI CTRad Academia-Pharma Joint Working Group
Jul 24, 2004·Expert Review of Anticancer Therapy·Susanne J RogersChristopher M Nutting
Jul 3, 2007·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·S SupiotM Chérel
Dec 8, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chinreddy Subramanyam ReddySung Cheol Koo
Jan 1, 2017·Current Stem Cell Reports·Chang-Kyung KimAgnieszka B Bialkowska
Sep 11, 2019·Journal of Radiation Research·Nariman K Badr El-DinMamdooh Ghoneum
Apr 5, 2019·Oncology Letters·Zhongsong ManZaixiang Tang
Apr 25, 2018·Journal of Experimental & Clinical Cancer Research : CR·Le TangZhaoyang Zeng
Jul 1, 2018·Military Medical Research·Jin-Song WangHai-Li Qian
Nov 15, 2018·Naunyn-Schmiedeberg's Archives of Pharmacology·Atilla TopcuTolga Mercantepe
Dec 1, 2006·Molecular and Cellular Biochemistry·Anirban Kumar MitraMalini Krishna
Aug 28, 2020·Frontiers in Oncology·Bin QiuJunjie Wang
Jan 17, 2009·Cancer Research·Philip P Connell, Samuel Hellman
Feb 20, 2007·Molecular Cancer Therapeutics·Nizar M MhaidatPeter Hersey
Apr 4, 2021·Cancers·Anaís Sánchez-CastilloKim R Kampen
Jun 16, 2021·Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)·Leslie PereiraLuís A G Magalhães
Jul 1, 2021·Molecular Carcinogenesis·Vidya GopalakrishnanSathees C Raghavan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.